The role of elastography in non-alcoholic fatty liver disease

被引：9

作者：

Liguori, Antonio ^{[1
]}

Ainora, Maria E. ^{[1
]}

Riccardi, Laura ^{[1
]}

De Matthaeis, Nicoletta ^{[1
]}

Pizzolante, Fabrizio ^{[1
]}

Gasbarrini, Antonio ^{[1
,2
]}

Zocco, Maria A. ^{[1
,2
]}

Grieco, Antonio ^{[1
,2
]}

Rapaccini, Gianludovico ^{[1
,2
]}

Miele, Luca ^{[1
,2
]}

机构：

[1] Sacred Heart Catholic Univ, IRCCS A Gemelli Univ Polyclin Fdn, Dept Med & Surg Sci, Largo Gemelli 8, I-00168 Rome, Italy

[2] Sacred Heart Catholic Univ, Dept Med & Translat Surg, Rome, Italy

来源：

MINERVA GASTROENTEROLOGY | 2021年 / 67卷 / 02期

关键词：

Non-alcoholic fatty liver disease; Review; Gastroenterology; MAGNETIC-RESONANCE ELASTOGRAPHY; RADIATION FORCE IMPULSE; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; DIAGNOSTIC-ACCURACY; NONINVASIVE TOOLS; FIBROSIS; METAANALYSIS; PERFORMANCE; MANAGEMENT;

D O I：

10.23736/S2724-5985.21.02801-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and its prevalence is even higher in patients with risk factors such as type 2 diabetes and obesity. Liver biopsy is the gold standard for diagnosis of non-alcoholic steatohepatitis (NASH), particularly for the assessment of fibrosis stage that is a key prognostic factor. Noninvasive methods for assessment of liver fibrosis are a huge need in contemporary hepatology in order to stratify patient's risk of advanced and progressive liver disease. In this perspective different imaging techniques have been developed in last decades and showed high performance in liver fibrosis evaluation. Strengths and weaknesses of all imaging methods are summarized in this review.

引用

页码：164 / 170

页数：7

共 50 条

[31] Non-alcoholic fatty Liver disease
Calderaro, Julien
Zafrani, Elie Serge
ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
[32] Non-alcoholic fatty liver disease
Farrell, Geoffrey C.
Wardell, Rebecca
Teoh, Narci
Chitturi, Shiv
INTERNAL MEDICINE JOURNAL, 2019, 49 (05) : 681 - 683
[33] Non-alcoholic fatty liver disease
Adams, LA
Angulo, P
LIVER DISEASES: ADVANCES IN TREATMENT AND PREVENTION: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 137 : 250 - 270
[34] Non-Alcoholic Fatty Liver Disease
Engin, Atilla
OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467
[35] Non-alcoholic fatty liver disease
Brent A. Neuschwander-Tetri
BMC Medicine, 15
[36] Non-alcoholic fatty liver disease
Alba, LM
Lindor, K
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
[37] Non-alcoholic fatty liver disease
Sattar, Naveed
Forrest, Ewan
Preiss, David
BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
[38] Non-alcoholic fatty liver disease
Li, Wenhao
Alazawi, William
CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
[39] The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Zhang, Chunye
Liu, Shuai
Yang, Ming
GASTROENTEROLOGY INSIGHTS, 2022, 13 (02) : 148 - 161
[40] The Role of Liver Biopsy to Assess Non-Alcoholic Fatty Liver Disease
Kobyliak, Nazarii
Abenavoli, Ludovico
REVIEWS ON RECENT CLINICAL TRIALS, 2014, 9 (03) : 159 - 169

← 1 2 3 4 5 →